
Sign up to save your podcasts
Or


In Part 4 of Michael Skok's Harvard i-lab lecture series, "Startup Secrets: An insiders guide to unfair competitive advantage," Skok describes the fundamentals of building a go-to-market strategy for your business.
Uploaded 07-05-12
You can read more about Michael Skok, and his Startup Secrets on his website: http://mjskok.com/ and follow him on twitter at http://twitter.com/mjskok
Learn more about the Harvard Innovation Lab at http://i-lab.harvard.edu/ and follow us on Twitter at http://twitter.com/innovationlab and like us on facebook at https://www.facebook.com/harvardinnovationlab
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
Note: There will NOT be a Longwood to ilab shuttle.
Uploaded 02-12-14
Information is a valuable asset to any life sciences or technology venture. This substantive session will help to frame data-related limitations, systems and practices that new companies are likely to encounter. The collection, analysis, storage and disclosure of information is often critical for developing and commercializing products, establishing strategic collaborations, securing regulatory approvals, and completing corporate acquisitions and other transactions.
When information includes personally identifiable information, it is necessary to address special regulatory and contractual considerations in a company’s earliest stages. By pursuing data privacy and security “by design,” startup companies can be prepared for the privacy and security landscape and, hopefully, avoid burdensome “retrofitting” efforts that can disrupt future growth.
You will learn:
- how to navigate the increasingly complex regulatory framework governing personally identifiable information, including the regulation of health-related data
- which key contractual issues affect your venture companies that handle such data through their license agreements, collaborations and sales contracts
This presentation will be led by partners of the WilmerHale law firm to provide an overview of key regulatory and contractual considerations most likely to affect life sciences and technology startup companies.
- Barry Hurewitz, Regulatory and Government Affairs practice
- Jeff Johnson, Technology Transaction and Licensing practice
Learn more about the Harvard Innovation Lab at http://i-lab.harvard.edu/ and follow us on Twitter at http://twitter.com/innovationlab and like us on Facebook athttps://www.facebook.com/harvardinnovationlab
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
The Other Side speaker series engages innovation luminaries from across the globe to share “the other side” of their journeys: their successes – and their failures – and their perspective on what it takes to excel in today’s complex world.
Uploaded 19-04-16
We were ecstatic to have Stéphane Bancel, President and CEO of Moderna Therapeutics, join us as our speaker in the Other Side series. Under Bancel’s leadership, Moderna has become one of the fastest-growing companies in the biotech industry, raising more than $1.2 billion since 2011 to develop messenger RNA therapeutics. Much of Moderna’s unprecedented rate of growth while Bancel has been at the helm can be attributed to how the company has leveraged its novel platform technology, as well as its spinout ventures and partnerships with AstraZeneca, Merck and Alexion. Prior to Moderna, Bancel was the CEO of bioMérieux, a world leader in the diagnostics industry, where he was named #1 CEO in the Biotechnology sector according to the 2011 Thomson Reuters Pan European EXTEL Study.
As we dove into the other side of Bancel’s journey, we learned about the various roles he’s played since graduating from Harvard business: From managing manufacturing at Eli Lilly to serving as Senior Partner at Flagship Ventures. More importantly, we discovered the underlying motivations that have contributed to his ambitious belief and vision for making Moderna one of the most successful and impactful biotech companies in the world.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
Uploaded 24-06-13
Learn more about your ad choices. Visit megaphone.fm/adchoices
In the race to get a startup idea off the ground, founders focus on getting a MVP completed, finding talent to expand the team and then, the much-dreaded exercise of raising money. In the frenzy of it all, they at times overlook the fundamental question of how will I (or I and my investors) make money? They have a general, very high level idea about the possible paths, but most of the time they have not homed in on the monetization path or actual business model. And, that is a mistake.
Uploaded 15-12-14
In this highly interactive session, Rudina Seseri of Fairhaven Capital, helps founders:
- determine the right monetization paths for both B2B and B2C businesses, and
- understand the ramifications of each business model.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
Michael Skok will share his roadmap of what is needed to build a startup, milestones along the way, and how to pull that pitch together to get the venture attention and funding your idea deserves. After the workshop you should have a better understanding of:
Uploaded 01-12-14
The holistic checklist to think through your venture in a business like plan.
What matters to a VC/Investor.
How to think about your roadmap from startup to public company
Joining the workshop is Paula Long, CEO of Data Gravity, to share her insights.
Want to dive deeper into Startup Secrets? Explore the interactive Startup Secrets Sandbox for frameworks, insights, and tools to help you build and scale your startup: https://bit.ly/3Cwv0nK
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
Uploaded 24-04-13
Learn more about your ad choices. Visit megaphone.fm/adchoices
The Harvard Innovation Lab welcomed Eric Paley, Managing Partner at Founder Collective, and Russ Wilcox, founder E Ink Corporation for a candid discussion about startups as an alternate career, as well as how to evaluate an opportunity at a startup relative to a more traditional job offer.
Uploaded 07-05-12
Learn more about the Harvard Innovation Lab at http://i-lab.harvard.edu/ and follow us on Twitter at http://twitter.com/innovationlab and like us on facebook at https://www.facebook.com/harvardinnovationlab
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
Meghan McCormick's first venture in Africa tried to build businesses from scratch. But then by taking an asset-based approach, she realized that if Africa's huge base of existing small businesses could each grow just a little - enough to hire just one employee a year — that would make a big dent in the continent's worrisome unemployment problem. OZÉ is now the top business app in Ghana on the Google Play Store.
Uploaded 26-07-18
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
Jeff Bussgang presented a Skillshare class entitled "Mastering the VC Game: How to Raise Your First Round of Capital" at the Harvard innovation lab on April 3, 2012. Jeff is a Senior Lecturer in Entrepreneurship at HBS and a General Partner at Flybridge Capital Partners.
Uploaded 26-04-12
Students learned about the startup financing landscape, how to find investors, how to pitch them, how to understand term sheets, and other tips for raising a first round of financing.
The seminar was intended to address questions like:
You've been working on a big idea and need financing to get it going: but how do you go about raising your first round of funding? What's the difference between angel, seed, and VC investors? How do you go about valuing your company and deciding on equity?
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
From the publisher's feed